Global Fund Lp Lind II Sells 381,676 Shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) major shareholder Global Fund Lp Lind II sold 381,676 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $3.36, for a total value of $1,282,431.36. Following the transaction, the insider now owns 1,049,430 shares of the company’s stock, valued at $3,526,084.80. This trade represents a 26.67 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

ReWalk Robotics Trading Down 10.4 %

LFWD stock traded down $0.23 during midday trading on Wednesday, hitting $1.98. The stock had a trading volume of 777,140 shares, compared to its average volume of 1,779,347. The business has a fifty day moving average price of $1.96 and a two-hundred day moving average price of $2.91. ReWalk Robotics Ltd. has a 1-year low of $1.41 and a 1-year high of $8.89. The firm has a market cap of $17.44 million, a P/E ratio of -0.80 and a beta of 2.08.

ReWalk Robotics (NASDAQ:LFWD) last announced its earnings results on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.08). ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. The business had revenue of $6.13 million for the quarter, compared to the consensus estimate of $8.38 million. During the same quarter in the previous year, the company earned ($0.56) EPS. On average, equities analysts anticipate that ReWalk Robotics Ltd. will post -1.78 EPS for the current year.

Institutional Trading of ReWalk Robotics

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned approximately 0.16% of ReWalk Robotics at the end of the most recent quarter. Institutional investors own 26.76% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “buy” rating and set a $13.00 price target on shares of ReWalk Robotics in a report on Wednesday, November 13th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.